Latest news
ImmunityBio (IBRX) Tests Its Valuation After UAE ANKTIVA Approval Expands Its Reach - simplywall.stsimplywall.st · Sun, 09 Aug 2026 17:32:03 GMTWhy ImmunityBio (IBRX) Is Up 6.6% After ANKTIVA’s UAE Expansion and Mixed Q2 Results – And What's Next - simplywall.stsimplywall.st · Sat, 08 Aug 2026 08:34:48 GMTIBRX Stock Rises Overnight: Investors Eye FDA Workshop On Anktiva After Exclusive Japan BCG Deal - stocktwits.comstocktwits.com · Sat, 08 Aug 2026 08:26:22 GMTIBRX Stock Extends 5-Day Losing Streak — Retail Traders Pin Hopes On ‘Incredibly Strong’ Anktiva Sales And Earnings Beat - stocktwits.comstocktwits.com · Sat, 08 Aug 2026 06:12:58 GMTImmunityBio Announces Partnership To Expand Access To Anktiva Across 30 Countries - stocktwits.comstocktwits.com · Sat, 08 Aug 2026 03:55:09 GMTIBRX Stock Jumps After-Hours: Bulls Cheer ‘Unstoppable’ Global Expansion Amid US Regulatory Heat For Anktiva - stocktwits.comstocktwits.com · Sat, 08 Aug 2026 01:14:17 GMTIBRX Stock Eyes Green Open Ahead Of Earnings — What Happened With Anktiva Over The Weekend - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 17:00:28 GMTHow High Can IBRX Stock Go Now? Here’s What Wall Street Thinks After Saudi Nod For Bladder Cancer Filing - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 14:31:40 GMT